What Is $FNY? The First Trust Mid Cap Growth AlphaDEX Fund Explained (2026)
$FNY is the First Trust Mid Cap Growth AlphaDEX Fund, an index ETF that holds about 225 mid cap U.S. growth stocks picked by a quant screen and rebalanced every quarter. It launched in April 2011, charges 0.73% a year, and manages about $535 million. It's not a plain mid cap growth index fund: it ranks stocks on momentum and sales growth and gives the top scorers more weight.
"$FNY" is one of the top searches that lands people on GrowthETFs.com, along with a bunch of searches for its "financial report." So let's do the whole thing: what it is, how the AlphaDEX screen actually works, what it holds, how it has done against cheaper mid cap funds, and where to find the official reports.
$FNY at a glance
| Detail | $FNY |
|---|---|
| Full name | First Trust Mid Cap Growth AlphaDEX® Fund |
| Issuer / adviser | First Trust Advisors L.P. |
| Index | Nasdaq AlphaDEX Mid Cap Growth™ Index |
| Inception | April 19, 2011 (Nasdaq) |
| Expense ratio | 0.73% |
| Holdings | 225 stocks |
| Net assets | About $535 million |
| Rebalance | Quarterly (reconstituted and rebalanced) |
| Median market cap | About $7.8 billion |
| Fiscal year end | July 31 |
Source: First Trust $FNY fund summary page, data as of November 6, 2026 (market cap as of October 30, 2026). See also our live $FNY fund page.
How the AlphaDEX screen picks stocks
This is the part most people miss. $FNY is technically an index fund, but it's nothing like a cap weighted index fund. The index starts with the Nasdaq US 600 Mid Cap Growth Index and then runs every stock through a scoring system.
- Growth factors: 3, 6 and 12 month price appreciation, sales to price, and one year sales growth.
- Only growth stocks qualify. Each stock gets a style label from Nasdaq, and only the ones labeled growth are eligible.
- The top 225 make the cut. They're split into five groups (quintiles) by score.
- Higher scores get more weight. The top quintile gets the biggest slice, and stocks are equal weighted within each quintile.
- Every quarter it starts over. The index is reconstituted and rebalanced quarterly.
In plain English: it's a momentum and growth tilt, with no single stock allowed to dominate. Three of the five factors are about recent price moves. So when a group of stocks has been running, $FNY leans into it, and when the trend breaks, it can get caught on the wrong side until the next rebalance.
That's very different from $VOT or $IJK, which basically hold mid cap growth stocks by size and let winners grow into bigger weights.
What does $FNY hold?
Because of the quintile weighting, no stock is big. The top 10 add up to only about 9% of the fund.
| # | Company | Weight |
|---|---|---|
| 1 | Glaukos Corporation | 1.04% |
| 2 | Concentra Group Holdings Parent | 0.94% |
| 3 | Victoria's Secret & Co. | 0.93% |
| 4 | Exelixis | 0.91% |
| 5 | Hinge Health | 0.91% |
| 6 | PACS Group | 0.91% |
| 7 | Chime Financial | 0.90% |
| 8 | Charles River Laboratories | 0.87% |
| 9 | Haemonetics | 0.87% |
| 10 | LifeStance Health Group | 0.87% |
Holdings as of November 6, 2026, excluding cash, from First Trust. Holdings change every quarter.
Notice how health care heavy that list is. Seven of the top 10 are health care names. That shows up in the sector mix too:
| Sector | Weight |
|---|---|
| Health Care | 26.29% |
| Information Technology | 20.99% |
| Industrials | 14.70% |
| Financials | 12.69% |
| Consumer Discretionary | 9.34% |
| Real Estate | 5.77% |
| All others | 10.22% |
Sector exposure as of November 6, 2026, from First Trust.
Health care being the biggest sector in a "growth" fund surprises people, since most big growth funds are tech first. But that's the screen at work. It goes where sales growth and momentum are this quarter, not where they were five years ago.
Size wise, the median holding is about a $7.8 billion company, with a range of roughly $2.6 billion to $25.7 billion. These are real mid caps, not mega caps wearing a mid cap label.
$FNY performance: how has it actually done?
Here are First Trust's official NAV returns through October 30, 2026, next to the indexes they publish beside it. Returns over one year are annualized.
| Fund / index | YTD | 1 year | 3 years | 5 years | 10 years |
|---|---|---|---|---|---|
| $FNY (NAV) | 7.67% | 5.45% | 20.67% | 5.44% | 13.12% |
| Nasdaq US 600 Mid Cap Growth (starting universe) | 3.85% | 2.42% | 17.43% | 2.08% | 10.55% |
| S&P MidCap 400 Growth | 11.94% | 13.05% | 17.24% | 5.92% | 11.05% |
| Russell 3000 (whole market) | 11.71% | 11.99% | 23.09% | 11.03% | 14.90% |
Source: First Trust, month end performance as of October 30, 2026. Past performance does not guarantee future results.
A few things jump out.
The screen has added value over its own starting universe. $FNY beat the plain Nasdaq US 600 Mid Cap Growth Index in every period shown, by about 2.6 points a year over 10 years. That's the AlphaDEX idea working, even after the 0.73% fee.
Against the S&P MidCap 400 Growth Index, it's mixed. $FNY is ahead over 3 and 10 years but behind over 1 and 5 years and well behind this year. That index is what $IJK tracks, at a fraction of the cost.
Mid cap growth as a whole has lagged the total market. Over 5 years, the Russell 3000 roughly doubled $FNY's annual return. If you owned a total market fund, you didn't miss much by skipping mid caps.
It also swings harder. First Trust reports a 3 year standard deviation of 18.76% for $FNY versus 15.93% for the S&P MidCap 400 Growth Index, and a beta of 1.12. In Q3 2026 alone, $FNY fell 10.90% at NAV.
$FNY vs $VOT vs $IJK vs $IWP
These are the mid cap growth funds people usually compare it with.
| ETF | Approach | Expense ratio | Holdings | Assets | Fee on $10,000 |
|---|---|---|---|---|---|
| $FNY | AlphaDEX factor screen | 0.73% | 225 | $0.54B | $73/yr |
| $VOT | Vanguard, by size | 0.05% | 121 | $17.9B | $5/yr |
| $IJK | S&P MidCap 400 Growth | 0.16% | 255 | $10.0B | $16/yr |
| $IWP | Russell Midcap Growth | 0.23% | 277 | $17.3B | $23/yr |
$FNY data from First Trust as of November 6, 2026. $VOT, $IJK and $IWP expense ratios, holdings counts and assets from StockAnalysis, November 2026. Fee examples are simple estimates.
The fee gap is the big one. $FNY costs about 15 times what $VOT costs. On $100,000 that's $730 a year versus $50. Over a decade, that difference compounds into real money, so the AlphaDEX screen has to earn it back every year just to break even.
Sometimes it has. Over 10 years, $FNY's 13.12% a year beat the S&P MidCap 400 Growth Index's 11.05%. But over 5 years and the past year, the cheaper index won. You're paying for a strategy, and strategies go through long dry spells.
If you want to line up the full total return history yourself, plug any two of these into ETFTotalReturns.com. For the large cap side, I compared the Vanguard funds in $VUG vs $VONG vs $MGK vs $VOOG, and the smaller end in the best small cap growth ETFs.
Where to find the $FNY financial report
A lot of people search for the "First Trust Mid Cap Growth AlphaDEX Fund financial report" or the PDF. Here's where it lives:
- First Trust's site: on the $FNY fund page, the News & Literature tab has the fact sheet, prospectus and the annual and semi-annual shareholder reports.
- SEC EDGAR: the fund files its shareholder reports with the SEC as part of a First Trust AlphaDEX ETF trust. Searching the fund's ticker on EDGAR pulls them up.
- Timing: $FNY's fiscal year ends July 31, so the annual report covers August through July, and the semi-annual report covers August through January.
The annual report is where you'll find the full holdings list, the financial statements, turnover and the fund's own explanation of how it performed. With a quarterly reconstitution, turnover is something worth checking there, since higher trading can mean higher hidden costs.
Does $FNY pay a dividend?
Not in any meaningful way. Distributions are small and irregular. The most recent one I found was $0.0297 per share with an ex-date of June 26, 2025, per StockAnalysis. Before that: $0.1415 in December 2024 and $0.3051 in September 2024. On a fund trading around $95, that's a rounding error.
That's normal. Mid cap growth companies reinvest their cash to grow. I always tell people to give every fund a job. $FNY's job, if you own it, is growth. If you need your portfolio to pay you, that's a different shelf, and it's what I built TopDividendETFs.com for. On the income side, TopDividendETFsPRO lets you compare yields, price decay and ratings across 130+ income ETFs.
Who is $FNY for?
- It might fit if you specifically want mid cap growth exposure with a momentum and sales growth tilt, and you believe a rules based factor screen can keep beating the plain index like it has over 10 years.
- It probably doesn't fit if you just want cheap, broad mid cap growth. $VOT at 0.05% and $IJK at 0.16% do that with billions in assets.
- It's not for income. The distributions are tiny and unpredictable.
- It's not a core holding for most people. A total market or S&P 500 fund already owns mid caps. $FNY is a tilt on top of that.
Here's how I look at it. A 0.73% fee isn't automatically a dealbreaker if the strategy has a real record, and $FNY does have one going back to 2011. But the last 5 years show the other side of momentum investing. When leadership flips fast, a quarterly screen chases yesterday's winners. You have to be okay with that if you own it.
The risks
- Higher cost. 0.73% a year is many times what the big mid cap growth index funds charge.
- Momentum whipsaw. Three of the five growth factors are price momentum. Sharp reversals can hurt, like the 10.90% drop in Q3 2026.
- More volatile. A 3 year standard deviation of 18.76% and a beta of 1.12, per First Trust.
- Sector drift. The screen can pile into whatever is working. Right now that's health care at over 26%.
- Smaller fund. About $535 million in assets and a 0.15% median bid/ask spread, wider than the giant index funds.
The takeaway
$FNY is First Trust's rules based mid cap growth ETF: 225 stocks picked by momentum and sales growth, weighted by score, rebalanced every quarter, for 0.73% a year. It has beaten its own starting universe across every period First Trust reports and topped the S&P MidCap 400 Growth Index over 10 years, but it trailed that cheaper index over the last 1 and 5 years and swings harder. If you want a factor tilt in mid cap growth, it's a real option with a long record. If you just want mid cap growth exposure, the low cost index funds are hard to beat. Either way, read the prospectus and the annual report before you buy.
FAQ
What is $FNY?
$FNY is the First Trust Mid Cap Growth AlphaDEX Fund, an ETF that tracks the Nasdaq AlphaDEX Mid Cap Growth Index. It holds about 225 mid cap U.S. growth stocks picked and weighted by momentum and sales growth scores, rebalanced quarterly. It launched April 19, 2011 and charges 0.73% a year.
What is the $FNY expense ratio?
0.73% a year, per First Trust. That's $73 a year on a $10,000 investment, compared with about $5 for $VOT (0.05%) and $16 for $IJK (0.16%).
How has $FNY performed?
Per First Trust, as of October 30, 2026, $FNY returned 13.12% a year over 10 years, 5.44% a year over 5 years and 5.45% over the past year at NAV. It beat its starting universe, the Nasdaq US 600 Mid Cap Growth Index, in every period, but trailed the S&P MidCap 400 Growth Index over 1 and 5 years.
Where can I find the First Trust Mid Cap Growth AlphaDEX Fund financial report?
The annual and semi-annual shareholder reports are on First Trust's $FNY page under News and Literature, and on SEC EDGAR. The fund's fiscal year ends July 31.
Does $FNY pay a dividend?
Only small, irregular distributions. The most recent was $0.0297 per share in June 2025, per StockAnalysis. It's a growth fund, not an income fund.
Growth builds the nest egg. Income pays the bills.
Funds like $FNY are compounding tools. When you're ready for the income side, PRO is the tool I built for it: compare yields, price decay and ratings across 130+ income ETFs in one place.
- Advanced filtering
- Ratings
- Live yields
- Price decay
- 130+ income ETFs
Related posts and pages
Disclaimer: This post is for educational and informational purposes only and is not financial advice or a recommendation to buy or sell any security. I am not a financial advisor. Do your own research and read the prospectus, and consider speaking with a licensed professional before investing. $FNY fund details, holdings, sector weights, fees, risk statistics and official NAV returns are from First Trust (fund data as of November 6, 2026; performance as of October 30, 2026). Distribution history and comparison fund expense ratios, holdings counts and assets are from StockAnalysis. Data as of November 8, 2026. Dollar examples are estimates. Data can be inaccurate or change. Past performance does not guarantee future results.